Cc1ccc(-n2nc3c(=O)n(CC(=O)Nc4ccccc4F)nc(C)c3c2C)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?